The White House has told lawmakers it will continue funding cost-sharing reduction payments under the Affordable Care Act, withdrawing the threat that it might end the support from negotiations over government funding. However, the White House could still end the payments at any time, and AHIP spokeswoman Kristine Grow called for a congressional appropriation to give insurers the certainty they need.
Although House Speaker Paul Ryan, R-Wis., is focused this week on passing a funding bill to avert a government shutdown, a vote on revised health care legislation is still possible if it has enough support to pass, according to spokeswoman AshLee Strong. The House Freedom Caucus endorsed the bill, but moderate Republicans have not.
The CMS chief actuary is expected to miss the Friday deadline for determining whether Medicare costs are rising fast enough to trigger the Independent Payment Advisory Board in 2018 as predicted last year by Medicare trustees.
Sales of Amgen's new cholesterol drug Repatha, a PCSK9 inhibitor with a list price of $14,000 a year, were $49 million in the first quarter, compared with an average of $71.6 million expected by analysts.
Generic competition looms on about 40 brand-name drugs over the next three years, with combined revenue of about $60 billion, says Sanford Bernstein analyst Tim Anderson. Some of those drugs are biologics, Anderson notes.
Tranexamic acid can stop postpartum hemorrhage, which kills some 100,000 women every year and forces emergency hysterectomies in low- and middle-income countries, according to the results of a six-year study in The Lancet. The drug was invented in the 1950s, costs less than $2 per dose, does not need to be refrigerated and reduced the rate of maternal bleeding deaths by a third when given within three hours.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications